• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


William Y. Rice III, MD

Latest:

Primary Care Referrals to Nephrology in Patients With Advanced Kidney Disease

Primary care physicians did not refer the majority of patients with severe nephropathy to specialists; nonreferred patients had fewer comorbidities and might be better kidney transplant candidates.


Keith Algozzine

Latest:

Contributor: Employers Are Turning to Virtual Care Options to Mitigate Costs

Virtual care not only means saved time and costs for employees, but improvements to employers' bottom lines, through more proactive management of health concerns, notes UCM Digital Health CEO and co-founder Keith Algozzine.


Antje Freytag, PhD

Latest:

Clinical and Economic Outcomes of a Collaborative Cardiology Care Program

Patients with chronic cardiac conditions benefited from a health care program that strengthened collaboration between general practitioners and cardiology specialists in Baden-Wuerttemberg, Germany.


Chelsey A. Petz, MD

Latest:

Statin Prescribing Patterns in Patient-Centered Medical Home Patients With NAFLD

In this study, authors assessed the proportion of patients with nonalcoholic fatty liver disease (NAFLD) receiving prescriptions for statins in primary care.


Dandan Liu, PhD

Latest:

Association of Physician Coordination With Interfacility Transfer Acceptance Timeliness

The authors reviewed physician-to-physician conversations during emergency transfer of patients with ST-segment elevation myocardial infarction and found that higher-quality physician coordination was associated with faster time to acceptance.


Leah P. Griffin, MS

Latest:

Remote Monitoring Saves Costs in Outpatient Negative Pressure Wound Therapy

Health insurance records of patients using negative pressure wound therapy (NPWT) revealed lower adjusted 90-day wound-related costs with remote therapy monitoring vs NPWT alone.


Catherine Hersey, MPH

Latest:

An Analysis of Medicare Accountable Care Organization Expense Reports

The authors of this study examined expense reports to understand how participants in Medicare’s Accountable Care Organization Investment Model spent to achieve program goals.


Cody Midlam, PharmD

Latest:

Out-of-Pocket Costs for Diabetes Medications in Employer-Sponsored Health Insurance Plans

Out-of-pocket costs of diabetes medications other than insulin can be quite high for individuals with employer-sponsored health insurance.


Tyler J. Dunn, PhD

Latest:

Impact of Food Affordability on Diabetes-Related Preventable Hospitalization

Medicaid enrollees residing in counties with greater food affordability had lower odds of preventable hospitalization related to diabetes.


Steven Kheloussi, PharmD, MBA

Latest:

Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists

This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.


Clive Fields, MD

Latest:

Primary Care Visit Cadence and Hospital Admissions in High-Risk Patients

Patients with congestive heart failure and/or chronic obstructive pulmonary disease who had more quarterly primary care visits had lower rates of hospitalizations during the COVID-19 pandemic.


Abhishek Janardan, BA

Latest:

Scaling Care Coordination Through Digital Engagement: Stepped-Wedge Trial Assessing Readmissions

This evaluation looks at a postdischarge digital engagement (PDDE) program using causal inference methods to examine the impact of PDDE on readmission.


Naomi Lynn Gerber, MD

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Kali S. Thomas, PhD, MA

Latest:

How Medicare Advantage Plans Use Data for Supplemental Benefits Decision-Making

This article presents findings from interviews conducted with executives from 29 Medicare Advantage plans regarding plan decision-making processes related to new social risk factor–related benefits.


David S. Mandell, ScD

Latest:

The Implementation of Opioid Prescribing Report Cards in Medicaid Managed Care: A Community Quality Collaborative

This article describes the Philadelphia Medicaid Opioid Prescribing Initiative that was launched by a multidisciplinary team and mailed local Medicaid providers individualized prescribing report cards.


Ge Bai, PhD, CPA

Latest:

Large Self-insured Employers Lack Power to Effectively Negotiate Hospital Prices

This study examines the ability of self-insured employers to negotiate hospital prices and the relationship between hospital prices and employer market power in the United States.


Timothy C. Pigg

Latest:

Contributor: Objective Documentation Protects Patient Access to Home Oxygen Therapy

Facing the challenges created by the COVID-19 pandemic, the US medical community has been forced to rapidly change and modernize the manner in which it delivers health care over the last year-and-a-half. 


Keith Crowland, MBA

Latest:

Advanced Care at Home at Scale in an Integrated Health Care System

Advanced care at home (otherwise known as hospital at home) can be scaled and provide care for a sizable portion of a hospital’s inpatient census, creating hospital capacity in an integrated delivery system.


Ranita Sharma, MD

Latest:

A Case-Control Study of Length of Stay Outliers

Length of stay outliers are associated with hospital-acquired infections, complications, and discharge to facility, as opposed to nonmodifiable risk factors like age and comorbidities.



Amy Ming-Fang Yen, PhD

Latest:

Impact of COVID-19 Pandemic on Accessibility of Taiwanese Medical Care

The COVID-19 pandemic disrupted access to routine medical care in community populations in Taiwan. The unmet needs should be emphasized as normal life resumes.


Jaimee Jones

Latest:

Best Practices Drive Better Payer Negotiations

In today's managed care environment, it is important that contracts between practices and payers include reciprocal language that affords a practice protection over processes, decisions, and changes to the agreement over time, while aligning with its business operation.


Bradley Crotty, MD, MPH

Latest:

Scaling Care Coordination Through Digital Engagement: Stepped-Wedge Trial Assessing Readmissions

This evaluation looks at a postdischarge digital engagement (PDDE) program using causal inference methods to examine the impact of PDDE on readmission.


Marc A. Bruijnzeels, PhD

Latest:

Identifying Complex Patients Using Adjusted Clinical Groups Risk Stratification Tool

In this study, the authors developed a method for use in primary care to identify a group of patients with complex care needs using Aggregated Diagnosis Groups.


Benjamin D. Hong, MS

Latest:

Contemporary Care Patterns in the Management of Small Renal Masses

An investigation of management patterns after initial radiographic diagnosis of small renal masses showed that early urologist referral was associated with guideline-concordant care.


Mark Micek, MD, MPH

Latest:

Collaborative Care Implementation: Lessons Learned

The authors drafted a “Shared Values of Collaborative Care” document with fundamental principles to make better group decisions in implementing collaborative care.


Heather Huang, MD

Latest:

Collaborative Care Implementation: Lessons Learned

The authors drafted a “Shared Values of Collaborative Care” document with fundamental principles to make better group decisions in implementing collaborative care.


Lorena Lopez-Gonzalez, PhD, MA

Latest:

Psoriatic Arthritis Treatment Patterns and Costs Among Pharmacologic Treatment–Naïve Patients

We present results of an analysis of IBM MarketScan databases that evaluates treatment patterns and health care costs for treatment-naïve patients with psoriatic arthritis.


Mariana P. Socal, MD, PhD

Latest:

The Price Paradox of Biosimilar-Like Long-Acting Insulin

Findings suggest that Basaglar was not less expensive for patients than Lantus. Empirical evaluation of biosimilar costs prior to automatic substitution is necessary.


Krupa D. Parekh, PharmD, MPH

Latest:

Impact of Co-pay Assistance on Patient, Clinical, and Economic Outcomes

Limited evidence from a literature review suggests that co-pay assistance was associated with improved treatment persistence/adherence across various diseases, with indirect evidence suggesting improvements in clinical outcomes.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.